The Spectrum of Cancers in West Africa: Associations with Human Immunodeficiency Virus

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Tanon, Aristophane ^a   Jaquet, Antoine ^b,c   Ekouevi, Didier K ^b,c   Akakpo, Jocelyn ^d   Adoubi, Innocent ^a   Diomande, Isidore ^e   Houngbe, Fabien ^d   Zannou, Marcel D ^d   Sasco, Annie J ^b,c   Eholie, Serge P ^a   Dabis, Francois ^b,c   Bissagnene, Emmanuel ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

^d CNHU   (Benin)

^e CHU de Cocody   (Côte d’Ivoire)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ANUS CANCER; ARTICLE; BENIN; CANCER DIAGNOSIS; CANCER THERAPY; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COTE D'IVOIRE; DISEASE ASSOCIATION; FEMALE; GENITAL TRACT CANCER; HIV TEST; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; KAPOSI SARCOMA; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; RISK; STATISTICAL MODEL; UTERINE CERVIX CANCER; WARD;

ADULT; ANTI-RETROVIRAL AGENTS; BENIN; CASE-CONTROL STUDIES; COMORBIDITY; COTE D'IVOIRE; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; LINEAR MODELS; LIVER NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; ODDS RATIO; PREVALENCE; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84868151856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048108     Document Type: Article

References (32)

1. Anonymous (2000) Concerted Action on SeroConversion to AIDS and Death in Europe. Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Lancet 355: 1158-1159.
2. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, et al. (2003) Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis 36: 1030-1038.
3. Bonnet F, Lewden C, May T, Heripret L, Jougla E, et al. (2004) Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101: 317-324.
4. Center for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19.
5. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, et al. (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187-194.
6. Shiels MS, Cole SR, Kirk GD, Poole C, (2009) A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 52: 611-622.
7. UNAIDS Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report. UNAIDS: Geneva, 2011. Available: http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf. Accessed 2012 Jan 15.
8. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 22: 873-882.
9. Newton R, Ngilimana PJ, Grulich A, Beral V, Sindikubwabo B, et al. (1996) Cancer in Rwanda. Int J Cancer 66: 75-81.
10. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, et al. (2001) A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92: 622-627.
11. Stein L, Urban MI, O'Connell D, Yu XQ, Beral V, et al. (2008) The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer 122: 2260-2265.
12. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, et al. (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118: 985-990.
13. Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, et al. (2010) The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One 5: e8621.
14. Echimane AK, Ahnoux AA, Adoubi I, Hien S, M'Bra K, et al. (2000) Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995-1997. Cancer 89: 653-663.
15. Fritz A, Percy C, Lang A, Shanmugaratnam K, Sobin L, et al. (2000) International classification of diseases for oncology, 3rd edition Geneva: World Health Oragnisation.
16. Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, et al. (2000) The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88: 489-492.
17. Eholie SP, Tanon KA, Folquet-Amorissani M, Ouattara I, Aba YT, et al. (2009) Impact of access to antiretroviral therapy in Cote d'Ivoire [French]. Med Trop (Mars) 69: 520-524.
18. Crum-Cianflone NF, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, et al. (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors' reply. AIDS 23: 1791-1792.
19. Naresh KN, Raphael M, Ayers L, Hurwitz N, Calbi V, et al. (2011) Lymphomas in sub-Saharan Africa- what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? Br J Haematol 154: 696-703.
20. Mantina H, Wiggill TM, Carmona S, Perner Y, Stevens WS, (2010) Characterization of Lymphomas in a high prevalence HIV setting. J Acquir Immune Defic Syndr 53: 656-660.
21. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99: 962-972.
22. Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, et al. (2008) Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 22: 301-306.
23. Ferlay J, Shin HR, Bray F, Forman D, Mathers C,et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available: http://globocan.iarc.fr. Accessed 2012 Mar 29.
24. IARC (2007) Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Human Papillomaviruses.Vol. 90. International Agency for Research on Cancer: Lyon.
25. Luchters SM, Vanden Broeck D, Chersich MF, Nel A, Delva W, et al. (2010) Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis 10: 18.
26. Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, et al. (2009) Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis 199: 1851-1861.
27. Jaquet A, Horo A, Charbonneau V, Ekouevi DK, Roncin L, et al. (2012) Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Cote d'Ivoire, 2010. Br J Cancer 107: 556-563.
28. Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Toure-Coulibaly K, Maurice C, et al. (2010) Assessing the relationship between HIV infection and cervical cancer in Cote d'Ivoire: a case-control study. BMC Infect Dis 10: 242.
29. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM, (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59-67.
30. Jobarteh M, Malfroy M, Peterson I, Jeng A, Sarge-Njie R, et al. (2010) Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J 7: 230.
31. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, et al. (2004) HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J Med Virol 74: 34-40.
32. UNAIDS Global report: UNAIDS report on the global AIDS epidemic 2010. UNAIDS: Geneva, 2010. Available: http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf. Accessed 2012 Apr 16.